A Phase-I, Open-label Trial in Healthy Female Subjects to Investigate the Effect of TMC435 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone.
Phase of Trial: Phase I
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Simeprevir (Primary) ; Ethinylestradiol/norethisterone
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Janssen R&D Ireland
- 01 Oct 2012 Results will be presented at the 63nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) according to a Medivir media release.
- 15 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.